Biotechnology Biohaven Reports Third Quarter 2020 Financial Results and Recent Business Developments November 9, 2020
Biotechnology Kleo Pharmaceuticals Presents Preclinical Proof-of-Concept Data on a Novel Chemical Conjugation Platform (MATE(TM)) at the Society for Immunotherapy of Cancer’s (SITC) 35th Annual Meeting November 9, 2020
Biotechnology Reata Announces Positive Results From Year 2 of the Pivotal Phase 3 CARDINAL Study of Bardoxolone Methyl in Patients with Alport Syndrome November 9, 2020
Biotechnology Pfizer and BioNTech Announce Vaccine Candidate Against COVID-19 Achieved Success in First Interim Analysis from Phase 3 Study November 9, 2020
Biotechnology Reata Pharmaceuticals, Inc. Announces Third Quarter 2020 Financial Results and Provides an Update on Business Operations and Clinical Development Programs November 9, 2020
Biotechnology ROSEN, RECOGNIZED INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important November 24 Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm – BMRN November 7, 2020
Biotechnology SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, BTU, GOCO, NKLA INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits November 6, 2020
Biotechnology DEADLINE FOR RETA INVESTORS: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc. November 6, 2020
Biotechnology RETA INVESTOR DEADLINE: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Reata Pharmaceuticals Inc. November 6, 2020
Search
Biotechnology
